Platelet depletion, platelet activation and coagulation during treatment with hemodialysis

References

• Grooteman MPC, Nubé MJ. Haemodialysis-related bio-incompatibility: fundamental aspects and clinical relevance. Neth J Med 1998;5:169–78.
   Google Scholar
• Bos JC, Grooteman MP, van Houte AJ, Schoorl M, van Limbeek J, Nubé MJ. Low polymorphonuclear cell degranulation during citrate anticoagulation: a comparison between citrate and heparin dialysis. Nephrol Dial Transplant 1997;12:1387–93.
   PubMedGoogle Scholar
• Gritters M, Schoorl M, Schoorl M, Bartels PCM, Grooteman MPC, Nubé MJ. The role of the extracorporeal circuit in the trapping and degranulation of platelets. Blood Purif 2009;28:253–9.
   PubMedGoogle Scholar
• Opatrny K Jr, Bouda M, Kohoutkova L, Sefrna F. A clinical study to assess the effect of heparin in dialyser rinsing solutions. Int J Artif Organs 1997;20:112–8.
   PubMedGoogle Scholar
• De Sanctis LB, Stefoni S, Cianciolo G, Coli L, Buscaroli A, Feliciangeli G, Borgnino LC, Bonetti M, Gregorini MC, De Giovanni P, Buttazzi R. Effect of different dialysis membranes on platelet function. A tool for biocompatibility evaluation. Int J Artif Organs 1996;19:404–10.
   PubMedGoogle Scholar
• Rossi E, Casali B, Regolisti G, Davoli S, Perazzoli F, Negro A, Sani C, Tumiati B, Nicoli D. Increased plasma levels of platelet derived growth Factor (PDGF BB + PDGF AB) in patients with never-treated mild essential hypertension. Am J Hypertens 1998;11:1239–43.
   PubMedGoogle Scholar
• Ciancolo G, Stefoni S, Donati G, De Pascalis A, Iannelli S, Manna C, Colì L, Bertuzzi V, La Manna G, Raimondi C, Boni P, Stefoni V. Intra- and post-dialytic platelet activation and PDGF-AB release: cellulose diacetate vs polysulfone membranes. Nephrol Dial Transplant 2001;16:1222–9.
   PubMedGoogle Scholar
• Gritters M, Borgdorff P, Grooteman MPC, Schoorl M, Schoorl M, Bartels PCM, Tangelder G-J, Nubé MJ. Platelet activation in clinical haemodialysis: LMWH as a major contributor to bio-incompatibility. Nephrol Dial Transplant 2008;23:2911–7.
   PubMed Web of Science ®Google Scholar
• White JG. Electron opaque structures in human platelets: which are or are not dense bodies? Platelets 2008;19:455–66.
   PubMed Web of Science ®Google Scholar
• Schoorl M, Schoorl M, Bartels PCM. Changes in platelet volume, morphology and RNA content in subjects treated with haemodialysis. Scand J Clin Lab Invest 2008;68:335–42.
   PubMed Web of Science ®Google Scholar
• Elshamaa MF, Elghouroury EA, Helmy A. Intradialytic and postdialytic platelet activation, increased platelet phosphatidylserine exposure and ultrastructural changes in platelets in children with chronic uremia. Blood Coagul Fibrinolysis 2009;20:230–9.
   PubMed Web of Science ®Google Scholar
• Lang T, Depka von M. Possibilities and limitations of thromboelastometry/thromboelastography. Hämostaseologie 2006;26 (Suppl. 1): S21–9.
   Google Scholar
• Bartels PCM, Schoorl M, Schoorl M, Wiering JGA, Nubé MJ. Activation of coagulation during treatment with haemodialysis. Scand J Clin Lab Invest 2000;60:283–90.
   PubMedGoogle Scholar
• Bartels PCM, Schoorl M, Schoorl M, Nubé MJ. Deviations in coagulation activation due to treatment with different haemodialysis membranes. Scand J Clin Lab Invest 2003;63:417–24.
   PubMed Web of Science ®Google Scholar
• Sagedal S, Hartmann A, Sundstrøm K, Bjørnsen S, Brosstad F. Anticoagulation intensity sufficient for haemodialysis does not prevent activation of coagulation and platelets. Nephrol Dial Transplant 2001;16:987–93.
   PubMed Web of Science ®Google Scholar
• Lowe GDO. Virchow's triad revisited: abnormal flow. Pathophysiol Haemost Thromb 2003/2004;33:455–7.
   PubMedGoogle Scholar
• Chung I, Lip GY. Virchow's triad revisited: blood constituents. Pathophysiol Haemost Thromb 2003/2004;33: 449–54.
   PubMedGoogle Scholar
• Blann AD. How a damaged blood vessel wall contributes to thrombosis and hypertension. Pathophysiol Haemost Thromb 2003/2004;33:445–8.
   PubMedGoogle Scholar
• Klinkmann H, Vienken J. Membranes for dialysis. Nephrol Dial Transplant 1995;10(Suppl. 3):39–45.
   PubMedGoogle Scholar
• Clark WR, Macias WL, Molitoris BA, Wang NH. Plasma protein adsorption to highly permeable hemodialysis membranes. Kidney Int 1995;48:481–8.
   PubMed Web of Science ®Google Scholar
• Mares J, Thongboonkerd V, Tuma Z, Moravec J, Matejovic M. Specific adsorption of some complement activation proteins to polysulfone dialysis membranes during hemodialysis. Kidney Int 2009;76:404–13.
   PubMed Web of Science ®Google Scholar
• Borgdorff P, Fekkes D, Tangelder GJ. Hypotension caused by extracorporeal circulation: serotonin from pump-activated platelets triggers nitric oxide release. Circulation 2002;106:2588–93.
   PubMedGoogle Scholar
• Sebekova K, Spustova V, Optatrny K Jr., Dzurik R. Serotonin and 5-hydroxyindole-acetic acid. Bratisl Lek Listy 2001;102:351–6.
   PubMedGoogle Scholar
• Pivac N, Mück-Šeler D, Barišic I, Jakovljević M, Puretić Z. Platelet serotonin concentration in dialysis patients with somatic symptoms of depression. Life Sci 2001;69: 2423–33.
   Google Scholar
• Ambuhl PM, Wüthrich RP, Korte W, Schmid L, Krapf R. Plasma hypercoagulability in haemodialysis patients: impact of dialysis and anticoagulation. Nephrol Dial Transplant 1997;12:2355–64.
   PubMedGoogle Scholar
• Gritters-van den Oever M, Grooteman MPC, Bartels PCM, Blankenstijn PJ, Bots ML, van den Dorpel MA, Schoorl, M, Schoorl M, ter Wee PM, Nubé MJ. Post-dilution haemodiafiltration and low-flux haemodialysis have dissimilar effects on platelets: a side study of CONTRAST. Nephrol Dial Transplant 2009;24:3461–8.
   PubMed Web of Science ®Google Scholar